Herantis Pharma Says Phase 1B Trial For Parkinson’s Treatment Meets Main, Secondary Goals - TradingView

Reuters | Oct. 7, 2025, 1:27 p.m. | Original
Herantis Pharma Says Phase 1B Trial For Parkinson’s Treatment Meets Main, Secondary Goals TradingView
Nvidia to continue sponsoring H-1B visas, Business Insider reports - Reuters Fed's Kashkari says he's skeptical AI is replacing workers, but it may push up rates - Reuters